HEADER TRANSFERASE 30-SEP-21 7SE9 TITLE CRYSTAL STRUCTURE OF HUMAN FIBRILLARIN IN COMPLEX WITH COMPOUND 1 FROM TITLE 2 SINGLE SOAK COMPND MOL_ID: 1; COMPND 2 MOLECULE: RRNA 2'-O-METHYLTRANSFERASE FIBRILLARIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 34 KDA NUCLEOLAR SCLERODERMA ANTIGEN,HISTONE-GLUTAMINE COMPND 5 METHYLTRANSFERASE,U6 SNRNA 2'-O-METHYLTRANSFERASE FIBRILLARIN; COMPND 6 EC: 2.1.1.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FBL, FIB1, FLRN; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS METHYLTRANSFERASE, S-ADENOSYL METHIONINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.SHI,I.M.EL-DEEB,V.MASIC,L.HARTLEY-TASSELL,A.MAGGIONI,M.VON AUTHOR 2 ITZSTEIN,T.VE REVDAT 2 18-OCT-23 7SE9 1 REMARK REVDAT 1 09-FEB-22 7SE9 0 JRNL AUTH Y.SHI,I.M.EL-DEEB,V.MASIC,L.HARTLEY-TASSELL,A.MAGGIONI, JRNL AUTH 2 M.V.ITZSTEIN,T.VE JRNL TITL DISCOVERY OF COFACTOR COMPETITIVE INHIBITORS AGAINST THE JRNL TITL 2 HUMAN METHYLTRANSFERASE FIBRILLARIN. JRNL REF PHARMACEUTICALS V. 15 2021 JRNL REFN ESSN 1424-8247 JRNL PMID 35056083 JRNL DOI 10.3390/PH15010026 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.1_4122 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 65967 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.8800 - 4.2200 0.99 4822 152 0.1809 0.1935 REMARK 3 2 4.2200 - 3.3500 1.00 4684 144 0.1658 0.2272 REMARK 3 3 3.3500 - 2.9200 1.00 4616 145 0.1851 0.2157 REMARK 3 4 2.9200 - 2.6600 1.00 4587 145 0.1901 0.2219 REMARK 3 5 2.6600 - 2.4700 1.00 4584 148 0.1899 0.2095 REMARK 3 6 2.4700 - 2.3200 1.00 4569 140 0.1787 0.2182 REMARK 3 7 2.3200 - 2.2000 1.00 4542 140 0.1833 0.2269 REMARK 3 8 2.2000 - 2.1100 1.00 4532 142 0.1904 0.2361 REMARK 3 9 2.1100 - 2.0300 1.00 4556 143 0.1941 0.2299 REMARK 3 10 2.0300 - 1.9600 1.00 4524 145 0.1985 0.2256 REMARK 3 11 1.9600 - 1.9000 1.00 4525 138 0.2129 0.2398 REMARK 3 12 1.9000 - 1.8400 1.00 4530 147 0.2299 0.2700 REMARK 3 13 1.8400 - 1.7900 1.00 4508 138 0.2305 0.2536 REMARK 3 14 1.7900 - 1.7500 0.97 4392 129 0.2513 0.3159 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.192 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.321 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 3740 REMARK 3 ANGLE : 1.074 5072 REMARK 3 CHIRALITY : 0.064 566 REMARK 3 PLANARITY : 0.008 658 REMARK 3 DIHEDRAL : 13.430 1390 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7SE9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000258899. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66058 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 48.880 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.64440 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2IPX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.75-3.3 M SODIUM FORMATE, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.80250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 69.27400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.80250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 69.27400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CE MET A 87 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 80 REMARK 465 ASN A 81 REMARK 465 ALA A 82 REMARK 465 GLY A 83 REMARK 465 LYS A 84 REMARK 465 ARG A 100 REMARK 465 GLY A 101 REMARK 465 LYS A 102 REMARK 465 GLU A 103 REMARK 465 ASP A 104 REMARK 465 LYS A 318 REMARK 465 VAL A 319 REMARK 465 LYS A 320 REMARK 465 ASN A 321 REMARK 465 SER B 80 REMARK 465 ASN B 81 REMARK 465 ALA B 82 REMARK 465 GLY B 83 REMARK 465 LYS B 84 REMARK 465 ARG B 100 REMARK 465 GLY B 101 REMARK 465 LYS B 102 REMARK 465 GLU B 103 REMARK 465 ASP B 104 REMARK 465 LYS B 318 REMARK 465 VAL B 319 REMARK 465 LYS B 320 REMARK 465 ASN B 321 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 156 -5.81 63.97 REMARK 500 ALA A 169 -134.14 55.83 REMARK 500 HIS B 156 -30.98 69.89 REMARK 500 ALA B 169 -130.23 47.74 REMARK 500 ALA B 238 18.45 -144.76 REMARK 500 REMARK 500 REMARK: NULL DBREF 7SE9 A 83 321 UNP P22087 FBRL_HUMAN 83 321 DBREF 7SE9 B 83 321 UNP P22087 FBRL_HUMAN 83 321 SEQADV 7SE9 SER A 80 UNP P22087 EXPRESSION TAG SEQADV 7SE9 ASN A 81 UNP P22087 EXPRESSION TAG SEQADV 7SE9 ALA A 82 UNP P22087 EXPRESSION TAG SEQADV 7SE9 SER B 80 UNP P22087 EXPRESSION TAG SEQADV 7SE9 ASN B 81 UNP P22087 EXPRESSION TAG SEQADV 7SE9 ALA B 82 UNP P22087 EXPRESSION TAG SEQRES 1 A 242 SER ASN ALA GLY LYS ASN VAL MET VAL GLU PRO HIS ARG SEQRES 2 A 242 HIS GLU GLY VAL PHE ILE CYS ARG GLY LYS GLU ASP ALA SEQRES 3 A 242 LEU VAL THR LYS ASN LEU VAL PRO GLY GLU SER VAL TYR SEQRES 4 A 242 GLY GLU LYS ARG VAL SER ILE SER GLU GLY ASP ASP LYS SEQRES 5 A 242 ILE GLU TYR ARG ALA TRP ASN PRO PHE ARG SER LYS LEU SEQRES 6 A 242 ALA ALA ALA ILE LEU GLY GLY VAL ASP GLN ILE HIS ILE SEQRES 7 A 242 LYS PRO GLY ALA LYS VAL LEU TYR LEU GLY ALA ALA SER SEQRES 8 A 242 GLY THR THR VAL SER HIS VAL SER ASP ILE VAL GLY PRO SEQRES 9 A 242 ASP GLY LEU VAL TYR ALA VAL GLU PHE SER HIS ARG SER SEQRES 10 A 242 GLY ARG ASP LEU ILE ASN LEU ALA LYS LYS ARG THR ASN SEQRES 11 A 242 ILE ILE PRO VAL ILE GLU ASP ALA ARG HIS PRO HIS LYS SEQRES 12 A 242 TYR ARG MET LEU ILE ALA MET VAL ASP VAL ILE PHE ALA SEQRES 13 A 242 ASP VAL ALA GLN PRO ASP GLN THR ARG ILE VAL ALA LEU SEQRES 14 A 242 ASN ALA HIS THR PHE LEU ARG ASN GLY GLY HIS PHE VAL SEQRES 15 A 242 ILE SER ILE LYS ALA ASN CYS ILE ASP SER THR ALA SER SEQRES 16 A 242 ALA GLU ALA VAL PHE ALA SER GLU VAL LYS LYS MET GLN SEQRES 17 A 242 GLN GLU ASN MET LYS PRO GLN GLU GLN LEU THR LEU GLU SEQRES 18 A 242 PRO TYR GLU ARG ASP HIS ALA VAL VAL VAL GLY VAL TYR SEQRES 19 A 242 ARG PRO PRO PRO LYS VAL LYS ASN SEQRES 1 B 242 SER ASN ALA GLY LYS ASN VAL MET VAL GLU PRO HIS ARG SEQRES 2 B 242 HIS GLU GLY VAL PHE ILE CYS ARG GLY LYS GLU ASP ALA SEQRES 3 B 242 LEU VAL THR LYS ASN LEU VAL PRO GLY GLU SER VAL TYR SEQRES 4 B 242 GLY GLU LYS ARG VAL SER ILE SER GLU GLY ASP ASP LYS SEQRES 5 B 242 ILE GLU TYR ARG ALA TRP ASN PRO PHE ARG SER LYS LEU SEQRES 6 B 242 ALA ALA ALA ILE LEU GLY GLY VAL ASP GLN ILE HIS ILE SEQRES 7 B 242 LYS PRO GLY ALA LYS VAL LEU TYR LEU GLY ALA ALA SER SEQRES 8 B 242 GLY THR THR VAL SER HIS VAL SER ASP ILE VAL GLY PRO SEQRES 9 B 242 ASP GLY LEU VAL TYR ALA VAL GLU PHE SER HIS ARG SER SEQRES 10 B 242 GLY ARG ASP LEU ILE ASN LEU ALA LYS LYS ARG THR ASN SEQRES 11 B 242 ILE ILE PRO VAL ILE GLU ASP ALA ARG HIS PRO HIS LYS SEQRES 12 B 242 TYR ARG MET LEU ILE ALA MET VAL ASP VAL ILE PHE ALA SEQRES 13 B 242 ASP VAL ALA GLN PRO ASP GLN THR ARG ILE VAL ALA LEU SEQRES 14 B 242 ASN ALA HIS THR PHE LEU ARG ASN GLY GLY HIS PHE VAL SEQRES 15 B 242 ILE SER ILE LYS ALA ASN CYS ILE ASP SER THR ALA SER SEQRES 16 B 242 ALA GLU ALA VAL PHE ALA SER GLU VAL LYS LYS MET GLN SEQRES 17 B 242 GLN GLU ASN MET LYS PRO GLN GLU GLN LEU THR LEU GLU SEQRES 18 B 242 PRO TYR GLU ARG ASP HIS ALA VAL VAL VAL GLY VAL TYR SEQRES 19 B 242 ARG PRO PRO PRO LYS VAL LYS ASN HET 8W1 A 401 22 HET FMT A 402 5 HET FMT A 403 5 HET FMT A 404 5 HET FMT A 405 5 HET FMT A 406 5 HET DMS A 407 10 HET 8W1 B 401 22 HET FMT B 402 5 HET FMT B 403 5 HET FMT B 404 5 HET DMS B 405 10 HETNAM 8W1 (5S)-3-METHYL-7-(TRIFLUOROMETHYL)PYRROLO[1,2-A]PYRAZIN- HETNAM 2 8W1 1(2H)-ONE HETNAM FMT FORMIC ACID HETNAM DMS DIMETHYL SULFOXIDE FORMUL 3 8W1 2(C9 H7 F3 N2 O) FORMUL 4 FMT 8(C H2 O2) FORMUL 9 DMS 2(C2 H6 O S) FORMUL 15 HOH *353(H2 O) HELIX 1 AA1 SER A 142 GLY A 150 1 9 HELIX 2 AA2 GLY A 171 GLY A 182 1 12 HELIX 3 AA3 SER A 193 ARG A 207 1 15 HELIX 4 AA4 HIS A 219 ILE A 227 5 9 HELIX 5 AA5 ASP A 241 PHE A 253 1 13 HELIX 6 AA6 ALA A 266 ASP A 270 1 5 HELIX 7 AA7 SER A 274 GLU A 289 1 16 HELIX 8 AA8 SER B 142 GLY B 150 1 9 HELIX 9 AA9 GLY B 171 GLY B 182 1 12 HELIX 10 AB1 SER B 193 LYS B 206 1 14 HELIX 11 AB2 HIS B 219 ILE B 227 5 9 HELIX 12 AB3 ASP B 241 PHE B 253 1 13 HELIX 13 AB4 ALA B 266 ASP B 270 1 5 HELIX 14 AB5 SER B 274 GLU B 289 1 16 SHEET 1 AA1 5 GLU A 89 PRO A 90 0 SHEET 2 AA1 5 VAL A 96 ILE A 98 -1 O ILE A 98 N GLU A 89 SHEET 3 AA1 5 VAL A 107 LYS A 109 -1 O VAL A 107 N PHE A 97 SHEET 4 AA1 5 ASP A 130 ALA A 136 -1 O ARG A 135 N THR A 108 SHEET 5 AA1 5 ARG A 122 GLU A 127 -1 N ILE A 125 O ILE A 132 SHEET 1 AA2 7 ILE A 210 VAL A 213 0 SHEET 2 AA2 7 LEU A 186 VAL A 190 1 N VAL A 187 O ILE A 211 SHEET 3 AA2 7 LYS A 162 LEU A 166 1 N TYR A 165 O TYR A 188 SHEET 4 AA2 7 VAL A 230 VAL A 237 1 O PHE A 234 N LEU A 166 SHEET 5 AA2 7 LEU A 254 LYS A 265 1 O SER A 263 N ALA A 235 SHEET 6 AA2 7 HIS A 306 TYR A 313 -1 O ALA A 307 N ILE A 264 SHEET 7 AA2 7 MET A 291 THR A 298 -1 N GLN A 294 O VAL A 310 SHEET 1 AA3 5 GLU B 89 PRO B 90 0 SHEET 2 AA3 5 VAL B 96 ILE B 98 -1 O ILE B 98 N GLU B 89 SHEET 3 AA3 5 VAL B 107 LYS B 109 -1 O VAL B 107 N PHE B 97 SHEET 4 AA3 5 ASP B 130 ALA B 136 -1 O ARG B 135 N THR B 108 SHEET 5 AA3 5 ARG B 122 GLU B 127 -1 N VAL B 123 O TYR B 134 SHEET 1 AA4 7 ILE B 210 VAL B 213 0 SHEET 2 AA4 7 LEU B 186 VAL B 190 1 N ALA B 189 O ILE B 211 SHEET 3 AA4 7 LYS B 162 LEU B 166 1 N TYR B 165 O TYR B 188 SHEET 4 AA4 7 VAL B 230 VAL B 237 1 O PHE B 234 N LEU B 166 SHEET 5 AA4 7 LEU B 254 LYS B 265 1 O SER B 263 N ALA B 235 SHEET 6 AA4 7 HIS B 306 TYR B 313 -1 O ALA B 307 N ILE B 264 SHEET 7 AA4 7 MET B 291 THR B 298 -1 N GLN B 294 O VAL B 310 CISPEP 1 GLU A 300 PRO A 301 0 6.73 CISPEP 2 GLU B 300 PRO B 301 0 6.90 CRYST1 67.605 138.548 68.967 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014792 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007218 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014500 0.00000